Append Medical

About:

Append Medical develops a next-generation transcatheter Left Atrial Appendage (LAA) closure system.

Website: https://www.appendmedical.com/

Top Investors: Boston Scientific, MEDX Xelerator, Intellectual Ventures, Shoni Health Ventures, ALIVE Israel HealthTech Fund

Description:

Append Medical develops a next-generation transcatheter Left Atrial Appendage (LAA) closure system. The Append Medical solution is in the pre-clinical in-vivo trial phase. It is intended to become a differentiated solution in the LAA closure market, which has been estimated to reach $25B within several years. This is the second-fastest growing segment of the medical device market, with potential sales of $500M in 2019. Append Medical is a member of MEDX Xelerator, a medtech incubator backed by Boston Scientific, Intellectual Ventures, MEDX Ventures and Sheba Medical Center.

Total Funding Amount:

$11.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Or Yehuda, Tel Aviv, Israel

Founded Date:

2015-01-01

Contact Email:

zachi.berger(AT)appendmedical.com

Founders:

Zachi Berger

Number of Employees:

1-10

Last Funding Date:

2023-07-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai